Globe Life (GL) Aktienübersicht
Globe Life Inc. bietet über seine Tochtergesellschaften verschiedene Lebens- und Krankenzusatzversicherungen für Familien mit niedrigem und mittlerem Einkommen in den Vereinigten Staaten an. Mehr Details
| Schneeflocken-Punktzahl | |
|---|---|
| Bewertung | 5/6 |
| Künftiges Wachstum | 1/6 |
| Vergangene Leistung | 4/6 |
| Finanzielle Gesundheit | 2/6 |
| Dividenden | 4/6 |
Belohnungen
Risikoanalyse
GL Community Fair Values
Create NarrativeSee what 18 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Globe Life Inc. Wettbewerber
Preisentwicklung & Leistung
| Historische Aktienkurse | |
|---|---|
| Aktueller Aktienkurs | US$156.75 |
| 52-Wochen-Hoch | US$157.92 |
| 52-Wochen-Tief | US$116.73 |
| Beta | 0.50 |
| 1 Monat Veränderung | 2.75% |
| 3 Monate Veränderung | 8.74% |
| 1 Jahr Veränderung | 28.21% |
| 3 Jahre Veränderung | 49.09% |
| 5 Jahre Veränderung | 47.91% |
| Veränderung seit IPO | 5,061.28% |
Aktuelle Nachrichten und Updates
Narrativ-Update • May 15
GL: Buybacks And Earnings Guidance Will Shape A Balanced Forward Outlook
Analysts have adjusted their price target for Globe Life to $147. This $1 change reflects updated views on slightly higher discount rates, more moderate revenue growth, a marginally stronger profit margin, and a modestly lower future P/E assumption.
Narrativ-Update • Apr 30
GL: Earnings Guidance And Buybacks Will Support Bullish Long Term Outlook
Analysts have kept their Globe Life price target steady at $199.00. This reflects only small adjustments to assumptions around revenue growth, profit margins, and future P/E that together leave their overall valuation view broadly unchanged.Recent updates
Narrativ-Update • May 15
GL: Buybacks And Earnings Guidance Will Shape A Balanced Forward Outlook
Analysts have adjusted their price target for Globe Life to $147. This $1 change reflects updated views on slightly higher discount rates, more moderate revenue growth, a marginally stronger profit margin, and a modestly lower future P/E assumption.Narrativ-Update • Apr 30
GL: Earnings Guidance And Buybacks Will Support Bullish Long Term Outlook
Analysts have kept their Globe Life price target steady at $199.00. This reflects only small adjustments to assumptions around revenue growth, profit margins, and future P/E that together leave their overall valuation view broadly unchanged.Narrativ-Update • Apr 15
GL: Updated Capital Returns And Slightly Lower P/E Assumptions Will Guide Balanced Outlook
Analysts now see Globe Life's fair value at $146.00, down from $150.00. This reflects slightly adjusted assumptions for revenue growth, profit margin and future P/E in their updated models.Narrativ-Update • Apr 01
GL: Higher P/E Assumptions And Capital Returns Will Shape Balanced Future Outcomes
Analysts have raised their price target on Globe Life to $150, up from $145. This change reflects updated assumptions for revenue growth, profit margins and future P/E multiples in their models.
Narrativ-Update • Mar 18
GL: Share Repurchases And Earnings Guidance Will Support Long-Term Upside
Analysts have adjusted their price target on Globe Life slightly higher to about $172 per share, reflecting updated assumptions for revenue growth, profit margin, discount rate, and future P/E. What's in the News Globe Life's board approved a quarterly dividend of $0.3300 per share, payable on May 1, 2026, to shareholders of record as of April 3, 2026 (Key Developments).Seeking Alpha • Mar 14
Globe Life: Undervalued Insurance For Your Portfolio
Summary Globe Life offers a compelling long-term dividend growth profile, despite its modest 0.8% yield, making it ideal for future-focused portfolios. GL’s affordable, sticky policies drive recurring revenue and organic growth, supported by a large underinsured market and expanding exclusive agent force. Trading at a 17% discount to a $171 fair value estimate, GL’s forward P/E of 9.2 is well below historical averages, positioning it for potential revaluation. With a low payout ratio and a 20-year dividend growth streak, GL targets double-digit annual dividend hikes and could deliver 11% annual total returns through 2031. Read the full article on Seeking AlphaNarrativ-Update • Mar 04
GL: Future Earnings Outlook And Buybacks Will Support Bullish View
Analysts have maintained their Globe Life price target at $199, citing updated model inputs that reflect slightly different assumptions for the discount rate, revenue growth, profit margin, and future P/E, while still arriving at the same fair value estimate. What's in the News Globe Life's board approved a quarterly dividend of $0.33 per share, payable on May 1, 2026, to shareholders of record as of April 3, 2026 (company announcement).Narrativ-Update • Feb 18
GL: Buybacks And Earnings Outlook Will Support Long-Term Upside
Analysts have adjusted their price target on Globe Life to $171.40 from $168.30. This reflects updated assumptions around revenue growth, profit margins, the discount rate, and future P/E expectations.Narrativ-Update • Feb 04
GL: Higher Revenue Outlook And P/E Assumptions Will Shape Balanced Future Returns
Analysts have lifted their price target on Globe Life from US$111.00 to US$145.00, citing updated assumptions for discount rates, revenue growth, profit margins, and future P/E, which together support a higher valuation framework. Valuation Changes Fair Value: price target updated from US$111.00 to US$145.00, representing a sizeable upward reset in the valuation estimate.Narrativ-Update • Jan 20
GL: Future Earnings Guidance And Buybacks Will Support Bullish View
Analysts have raised their price target on Globe Life from about $185 to $199, citing updated assumptions for fair value, discount rate, revenue growth, profit margins and future P/E. What's in the News Globe Life issued earnings guidance for 2025, projecting net operating income between $14.40 and $14.60 per diluted common share for the year ending December 31, 2025 (company guidance).Narrativ-Update • Jan 06
GL: Steady Outlook And Ongoing Buybacks Will Support Long-Term Upside
Analysts have kept their price target for Globe Life broadly steady around $168.30, reflecting minor adjustments to assumptions for revenue growth, profit margin and future P/E that did not materially change their overall valuation view. What's in the News Globe Life issued earnings guidance for 2025, projecting net operating income between $14.40 and $14.60 per diluted share for the year ending December 31, 2025 (Key Developments).Narrativ-Update • Dec 21
GL: Future Earnings Visibility And Buybacks Will Drive Long-Term Upside Potential
Analysts have raised their price target on Globe Life by approximately 1 dollar to reflect slightly higher modeled fair value, modestly improved margin and growth assumptions, and a marginally higher future P E multiple. What's in the News Issued earnings guidance for 2025, projecting net operating income of $14.40 to $14.60 per diluted share, signaling steady profit expectations (company guidance) Provided 2026 outlook with net operating income per share estimated between $14.60 and $15.30, suggesting continued earnings growth beyond next year (company guidance) Repurchased 1,274,691 shares between July 1 and September 30, 2025, equal to 1.57% of shares outstanding, for $172.95 million (buyback update) Reached 98.88% completion of a long running share repurchase program, totaling 143,773,686 shares bought back for $9,831.8 million since its announcement in August 2005 (buyback update) Valuation Changes Fair Value: increased slightly from $166.70 to $168.30 per share, reflecting a modestly higher modeled intrinsic value.Narrativ-Update • Dec 07
GL: Expanding Earnings Guidance Will Drive Long-Term Upside Potential
Analysts have modestly raised their price target on Globe Life to approximately $166.70 per share from about $166.27. They cite slightly stronger projected profit margins, a marginally lower discount rate, and a small uptick in expected revenue growth and future earnings multiples.Narrativ-Update • Nov 23
GL: Share Buyback Momentum And Earnings Guidance Will Drive Upside
Narrative Update on Globe Life: Analyst Price Target Adjustment Analysts have slightly lowered their fair value estimate for Globe Life by $0.18 to $166.27, citing marginal changes in projected revenue growth and profit margin expectations. What's in the News Globe Life Inc.Narrativ-Update • Nov 08
GL: Share Repurchases And Earnings Guidance Will Drive Future Upside
Analysts have raised their price target for Globe Life slightly, increasing it from $166.27 to $166.45, based on adjusted expectations for revenue growth and profitability. What's in the News Globe Life Inc.Narrativ-Update • Oct 25
Share Repurchases And Earnings Outlook Will Support Insurance Sector Expansion
Narrative Update: Globe Life Analyst Price Target Revision Analysts have slightly raised their fair value estimate for Globe Life, increasing the target from $165.73 to $166.27 per share. This change reflects improved expectations for profit margin and a stable growth outlook.Narrativ-Update • Oct 11
Digital Underwriting And Agent Expansion Will Shape Insurance Future
Narrative Update: Globe Life Analyst Price Target Adjustment Analysts have raised their fair value estimate for Globe Life from $161.55 to $165.73, citing modest improvements in projected revenue growth and a slightly lower discount rate as key factors supporting the upward adjustment. What's in the News Globe Life Inc.Narrativ-Update • Sep 27
Digital Underwriting And Agent Expansion Will Shape Insurance Future
Globe Life’s valuation metrics, including Future P/E and Discount Rate, remained essentially stable, resulting in only a marginal increase in the consensus Analyst Price Target from $160.18 to $161.55. What's in the News SEC concludes its investigation of Globe Life and does not intend to recommend an enforcement action.Seeking Alpha • Jan 23
Globe Life: A Stalwart That Can Balance Growth And Profitability
Summary Globe Life demonstrates steady EPS growth due to disciplined underwriting and cost efficiency. The company targets lower to middle-income families, maintaining stable annualized premiums and high underwriting margins. Globe Life's strong liquidity, high RBC ratio, and quality investment portfolio bolster its financial health. Shares are a buy with long-term price target of $180. Read the full article on Seeking AlphaSeeking Alpha • Sep 13
Globe Life: Boring, Which Is Good As A Policyholder-But Not As An Investor
Summary Globe Life's stable share price and low dividend yield make it a lackluster investment with limited growth potential and better alternatives available. The company’s business model and performance are respectable, but there are no significant catalysts for future gains. Despite a recent share buyback, Globe Life trails its peers and broader market indices in total return, making it a "pass" for investors. Read the full article on Seeking Alpha
Neues Narrativ • Aug 25
Enhanced Credibility And Strategic Growth Initiatives Promise Bright Prospects
Audit Committee's findings boost Globe Life's credibility and investor confidence by clarifying financial integrity, influencing stock value positively.Seeking Alpha • Jun 24
Globe Life: A Small Bet That The Recent Controversy Will Blow Over
Summary Globe Life Inc. shares rebounded sharply after a short report by Fuzzy Panda, caused a short-lived over 50% drop in the stock. Despite the controversy, Globe Life reported strong 1Q24 financials, increased its FY24 outlook, and has seen some recent insider purchases in the shares. Allegations of fraud and misconduct did prompt the SEC to open an informal inquiry. Despite the rebound, the stock is still cheap on a P/E basis. An analysis around Globe Life follows in the paragraphs below. Read the full article on Seeking AlphaSeeking Alpha • Apr 15
Globe Life: Betting On A Bounce To $80
Summary Globe Life experienced a significant drop in stock price after a report from Fuzzy Panda Research accused the company of unethical practices. The report compared Globe Life to other life insurance companies to build its negative narrative but did not assess industry standards or behaviors. In particular, Primerica. Fuzzy Panda held a $64.35 price target. GL has dropped below that mark. GL now has valuation metrics well below the industry average and significantly below PRI, it's most direct comparable as a life insurance company with an MLM sales structure. I believe that the stock price will bounce back to $80 or higher due to short sellers covering their positions and bullish investor speculation. Read the full article on Seeking AlphaAktionärsrenditen
| GL | US Insurance | US Markt | |
|---|---|---|---|
| 7D | 4.6% | -0.6% | 1.2% |
| 1Y | 28.2% | -6.7% | 28.7% |
Rendite im Vergleich zur Industrie: GL übertraf die Branche US Insurance , die im vergangenen Jahr eine Rendite von -6.7 erzielte.
Rendite vs. Markt: GL entspricht dem US Markt, der im vergangenen Jahr eine Rendite von 28.7 erzielte.
Preisvolatilität
| GL volatility | |
|---|---|
| GL Average Weekly Movement | 2.8% |
| Insurance Industry Average Movement | 4.4% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.4% |
| 10% least volatile stocks in US Market | 3.1% |
Stabiler Aktienkurs: GL hatte in den letzten 3 Monaten im Vergleich zum US -Markt keine signifikante Preisvolatilität.
Volatilität im Zeitverlauf: GLDie wöchentliche Volatilität (3%) ist im vergangenen Jahr stabil geblieben.
Über das Unternehmen
| Gegründet | Mitarbeiter | CEO | Website |
|---|---|---|---|
| 1900 | 3,695 | Frank Svoboda | home.globelifeinsurance.com |
Globe Life Inc. bietet über seine Tochtergesellschaften verschiedene Lebens- und Krankenzusatzversicherungsprodukte für Familien mit mittlerem und niedrigem Einkommen in den Vereinigten Staaten an. Das Unternehmen ist in drei Segmenten tätig: Lebensversicherung, Krankenzusatzversicherung und Investitionen. Das Unternehmen bietet Voll-, Risiko- und andere Lebensversicherungsprodukte sowie Lebensversicherungen für Kinder an; außerdem Medicare-Zusatzversicherungen und Krankenzusatzversicherungen mit begrenztem Leistungsumfang, wie Unfall-, Krebs-, Critical-Illness-, Herz-, Intensivpflege- und andere Gesundheitsprodukte, sowie Endvergütungs-, Unfalltod-, Hypothekenschutz- und Krankenhausversicherungsprodukte.
Globe Life Inc.'s Grundlagenzusammenfassung
| GL grundlegende Statistiken | |
|---|---|
| Marktanteil | US$12.13b |
| Gewinn(TTM) | US$1.18b |
| Umsatz(TTM) | US$6.07b |
10.3x
Kurs-Gewinn-Verhältnis 2.0x
Kurs-Umsatz-VerhältnisIst GL zu teuer?
Siehe Fair Value und BewertungsanalyseErträge & Einnahmen
| GL Gewinn- und Verlustrechnung (TTM) | |
|---|---|
| Einnahmen | US$6.07b |
| Kosten der Einnahmen | US$4.02b |
| Bruttogewinn | US$2.05b |
| Sonstige Ausgaben | US$871.51m |
| Gewinn | US$1.18b |
Zuletzt gemeldete Gewinne
Mar 31, 2026
Datum des nächsten Gewinnberichts
k.A.
| Gewinn per Aktie (EPS) | 15.16 |
| Bruttomarge | 33.73% |
| Nettogewinnspanne | 19.38% |
| Schulden/Eigenkapital-Verhältnis | 53.6% |
Wie hat sich GL auf lange Sicht entwickelt?
Historische Performance und VergleicheDividenden
0.8%
Aktuelle Dividendenrendite8%
AusschüttungsquoteZahlt GL eine zuverlässige Dividende?
Siehe GL Dividendenhistorie und Benchmarks| Globe Life Dividendentermine | |
|---|---|
| Ex-Dividenden Datum | Jul 06 2026 |
| Datum der Dividendenzahlung | Jul 31 2026 |
| Tage bis Ex-Dividende | 40 days |
| Tage bis zum Datum der Dividendenzahlung | 65 days |
Zahlt GL eine zuverlässige Dividende?
Siehe GL Dividendenhistorie und BenchmarksUnternehmensanalyse und Finanzdaten Status
| Daten | Zuletzt aktualisiert (UTC-Zeit) |
|---|---|
| Unternehmensanalyse | 2026/05/26 22:50 |
| Aktienkurs zum Tagesende | 2026/05/26 00:00 |
| Gewinne | 2026/03/31 |
| Jährliche Einnahmen | 2025/12/31 |
Datenquellen
Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.
| Paket | Daten | Zeitrahmen | Beispiel US-Quelle * |
|---|---|---|---|
| Finanzdaten des Unternehmens | 10 Jahre |
| |
| Konsensschätzungen der Analysten | +3 Jahre |
|
|
| Marktpreise | 30 Jahre |
| |
| Eigentümerschaft | 10 Jahre |
| |
| Verwaltung | 10 Jahre |
| |
| Wichtige Entwicklungen | 10 Jahre |
|
* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.
Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.
Analysemodell und Schneeflocke
Einzelheiten zu dem Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite. Außerdem bieten wir Leitfäden zur Verwendung unserer Berichte und Tutorials auf YouTube an.
Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.
Metriken für Industrie und Sektor
Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.
Analysten-Quellen
Globe Life Inc. wird von 30 Analysten beobachtet. 8 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.
| Analyst | Einrichtung |
|---|---|
| Jay Gelb | Barclays |
| Jack Matten | BMO Capital Markets Equity Research |
| null null | BMO Capital Markets Equity Research |